Virtus ETF Advisers LLC - Q2 2021 holdings

$243 Million is the total value of Virtus ETF Advisers LLC's 399 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 100.0% .

 Value Shares↓ Weighting
APRE ExitAPREA THERAPEUTICS INC$0-10,454
-100.0%
-0.02%
ODT ExitODONATE THERAPEUTICS INC$0-19,421
-100.0%
-0.03%
CALA ExitCALITHERA BIOSCIENCES INC$0-61,161
-100.0%
-0.06%
VYGR ExitVOYAGER THERAPEUTICS INC$0-35,712
-100.0%
-0.07%
TCDA ExitTRICIDA INC$0-38,593
-100.0%
-0.09%
CNST ExitCONSTELLATION PHARMCETICLS I$0-9,500
-100.0%
-0.09%
NXTC ExitNEXTCURE INC$0-24,419
-100.0%
-0.10%
OYST ExitOYSTER PT PHARMA INC$0-14,995
-100.0%
-0.12%
PPR ExitVOYA PRIME RATE TRsh ben int$0-59,445
-100.0%
-0.12%
EFF ExitEATON VANCE FLTG RATE INCOM$0-17,104
-100.0%
-0.12%
KZR ExitKEZAR LIFE SCIENCES INC$0-54,313
-100.0%
-0.14%
FPRX ExitFIVE PRIME THERAPEUTICS INC$0-17,112
-100.0%
-0.27%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VERTEX PHARMACEUTICALS INC31Q3 20231.7%
REGENERON PHARMACEUTICALS31Q3 20231.8%
INCYTE CORP31Q3 20232.1%
ENANTA PHARMACEUTICALS INC31Q3 20232.2%
EXELIXIS INC31Q3 20231.8%
VANDA PHARMACEUTICALS INC31Q3 20231.7%
IRONWOOD PHARMACEUTICALS INC31Q3 20232.0%
LIGAND PHARMACEUTICALS INC31Q3 20231.5%
GILEAD SCIENCES INC31Q3 20231.6%
HALOZYME THERAPEUTICS INC31Q3 20231.7%

View Virtus ETF Advisers LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-15
13F-HR2023-11-07
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View Virtus ETF Advisers LLC's complete filings history.

Compare quarters

Export Virtus ETF Advisers LLC's holdings